↓ Skip to main content

Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.

Overview of attention for article published in Vaccine, September 2008
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

f1000
1 research highlight platform

Readers on

mendeley
15 Mendeley
Title
Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice.
Published in
Vaccine, September 2008
DOI 10.1016/j.vaccine.2008.03.098
Pubmed ID
Authors

Jorma Hinkula, Marie Hagbom, Britta Wahren, Ulf Schroder

Abstract

There is a need for safe and potent adjuvants capable of delivering vaccine candidates over the mucosal barrier, with good capacity to stimulate both mucosal and systemic cell-mediated and humoral immunity. An adjuvant aimed for intranasal delivery should preferably deliver the antigen and minimize the transfer into the close proximity of the central nervous system, thus avoiding damage on the olfactory tissues. Advantages with a mucosal delivery route would be to provide mucosal and systemic immunity, requiring lower vaccine doses then when given parentally. The aim of this study was to study if the N3 adjuvant intranasally administered with HIV DNA plasmids would be transferred into the olfactory tissues and cause local inflammation and tissue damage.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 67%
Student > Master 2 13%
Professor 1 7%
Student > Ph. D. Student 1 7%
Professor > Associate Professor 1 7%
Other 0 0%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 40%
Immunology and Microbiology 4 27%
Medicine and Dentistry 3 20%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Unspecified 1 7%
Other 0 0%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2008.
All research outputs
#2,016,356
of 3,629,179 outputs
Outputs from Vaccine
#1,285
of 2,427 outputs
Outputs of similar age
#100,177
of 231,895 outputs
Outputs of similar age from Vaccine
#51
of 118 outputs
Altmetric has tracked 3,629,179 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,427 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,895 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.